Clinical evaluation of a cancer antigen CA 125 associated with ovarian cancer. (IV) Serum CA 125 levels through normal menstrual cycle and in benign diseases
Suzuki, M.; Sekiguchi, I.; Ohwada, M.; Tamada, T.; Sakurabayashi, I.; Kawai, T.
Rinsho Byori. Japanese Journal of Clinical Pathology 33(3): 285-288
1985
ISSN/ISBN: 0047-1860 PMID: 3859676 Document Number: 257577
Document emailed within 1 workday
Related Documents
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177Jia, M.C.; Zhou, L.Y.; Ren, S.; Dong, L.; Xiao, B. 1992: Serum SHBG levels during normal menstrual cycle and after insertion of levonorgestrel-releasing IUD Advances in Contraception: the Official Journal of the Society for the Advancement of Contraception 8(1): 33-40
Menendez-Botet, C.J.; Oettgen, H.F.; Pinsky, C.M.; Schwartz, M.K. 1978: A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms Clinical Chemistry 24(6): 868-872
Lussier-Cacan, S.; Xhignesse, M.; Desmarais, J.L.; Davignon, J.; Kafrissen, M.E.; Chapdelaine, A. 1991: Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy Metabolism, Clinical and Experimental 40(8): 849-854
Einhorn, N.; Bast, R.C.; Knapp, R.C.; Tjernberg, B.; Zurawski, V.R. 1986: Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer Obstetrics and Gynecology 67(3): 414-416
Amayo, A.; Obara, W. 2004: Serum prostate specific antigen levels in men with benign prostatic hyperplasia and cancer of prostate East African Medical Journal 81(1): 22-26
Pérez-Palacios, G.; Iramain, C.A.; Castañeda, E.; Rojo, B.; Long, D.W.; Scaglia, H.; Gual, C. 1973: Plasma profile of pituitary gonadotropins and ovarian steroids in the normal menstrual cycle Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 25(4): 305-313
Andersson, O.; Blombäck, M.; Bremme, K.; Wramsby, H. 1997: Prediction of changes in levels of haemostatic variables during natural menstrual cycle and ovarian hyperstimulation Thrombosis and Haemostasis 77(5): 901-904
Zmudziński, J.; Zmudzińska, M.; Niepsuj, K.; Lewandowski, J. 1988: Carcinoembryonic antigen levels in the serum and gastric juice of patients with cancer of the stomach and in patients with various non-neoplastic diseases of the digestive tract Polski Tygodnik Lekarski 43(47): 1496-1499
Goncharova, V.N.; Morozova, M.S.; Razina, L.G.; Murashko, L.E.; Sidel'nikova, V.M. 1987: Prostaglandin and cAMP levels in the endometrium of women with a normal menstrual cycle Problemy Endokrinologii 33(1): 29-32
Sakurabayashi, I.; Yamada, T.; Kawai, T.; Yamanaka, T. 1986: Clinical evaluation of a pancreatic cancer-associated glycoprotein antigen, DU-PAN-2. I. Enzymeimmunoassay and distribution of serum values in healthy persons Rinsho Byori. Japanese Journal of Clinical Pathology 34(6): 705-710
Bozkurt, M.; Yumru, A.E.; Aral, I. 2013: Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy European Journal of Gynaecological Oncology 34(6): 540-544
Stall, K.E.; Martin, E.W. 1981: Plasma carcinoembryonic antigen levels in ovarian cancer patients: a chart review and survey of published data Journal of Reproductive Medicine 26(2): 73-79
Capobianco, G.; Marras, V.; Battista Meloni, G.; Dessole, S.; Ashqar, N.; Cherchi, C.; Dessole, F.; Cherchi, P.L. 2012: Immunohistochemical evaluation of a new epithelial antigen, BER-EP4 in ovarian cancer: a propos of 62 cases European Journal of Gynaecological Oncology 33(1): 90-92
Stenman, U.H.; Leinonen, J.; Alfthan, H.; Rannikko, S.; Tuhkanen, K.; Alfthan, O. 1991: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Cancer Research 51(1): 222-226
Harmenberg, U.; Wahren, B.; Wiechel, K.L. 1988: Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract Cancer Research 48(7): 1985-1988
Sehouli, J.; Akdogan, Z.; Heinze, T.; Könsgen, D.; Stengel, D.; Mustea, A.; Lichtenegger, W. 2003: Preoperative determination of CASA (Cancer Associated Serum Antigen) and CA-125 for the discrimination between benign and malignant pelvic tumor mass: a prospective study Anticancer Research 23(2a): 1115-1118
Lang, B.A.; Kocent, A.; Nekulová, M.; Hlávková, J. 1984: Three-year follow-up of carcinoembryonal antigen levels in the serum of patients with breast cancer Neoplasma 31(1): 79-87
Namysłowski, G.; Klimala, J. 1998: The evaluation of carcinoembryonic antigen (CEA) levels in patients with laryngeal cancer Otolaryngologia Polska 52(2): 169-174
Gonzalez-Garza, M.T.; Pacheco-Cano, M.G.; Romero-Villaseñor, G. 1977: Comparison of the antitrypsin activity levels in serum of normal subjects and cancer patients Archivos de Investigacion Medica 8(1): 39-46